Vitamin K: A potential Liver Cancer treatment way
<p>A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Girji |
| Almmustuhtton: |
Archives of Hepatitis Research - Peertechz Publications,
2017-09-26.
|
| Fáttát: | |
| Liŋkkat: | Connect to this object online. |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ahr_000017 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Sofi a Dahlberg |e author |
| 700 | 1 | 0 | |a Ulf Schött |e author |
| 245 | 0 | 0 | |a Vitamin K: A potential Liver Cancer treatment way |
| 260 | |b Archives of Hepatitis Research - Peertechz Publications, |c 2017-09-26. | ||
| 520 | |a <p>A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago.</p> | ||
| 540 | |a Copyright © Sofi a Dahlberg et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Review Article |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ahr.000017 |z Connect to this object online. |